Skip to main content
. 2005 Jan;43(1):30–35. doi: 10.1128/JCM.43.1.30-35.2005

TABLE 5.

Methods used by participating laboratories with EQA panel 2

Characteristic Lab 1 Lab 2 Lab 3 Lab 4 Lab 7 Lab 8 Lab 9 Lab 10 Lab 11
In-house method Yes Yes Yes Yes Yes Yes Yes Yes Yes
Concentration of sample No No No No No No No No Centrifugation
Extraction method Boil Silicaa GuSCNb MagnaPurec Qiagend Boil Qiagen Amplicore Qiagen
Eq. sample used for PCRf 1 5 4 20 8 or 20 10 12.5 5 12.5
Amplification method Single PCR Real time Nested PCR Real time Real time Nested PCR Real time Real time Real time
Target gene IS481-IS1001 ?g IS481-IS1001 IS481-IS1001 IS481-IS1001 ? IS481 + ptxA Prh IS481 Pertactin
Detection method Gel Taqmani Gel Taqman Taqman Gel FRET probe Taqman Taqman
Analytical sensitivity (per ml) 1,000 CFU Unknown Unknown Unknown 125 CFU 10 cells 200 CFU Unknown Unknown
No. of separate areas 3 3 4 1 3 4 3 3 2
Carryover prevention No dUTPj No dUTP No No dUTP dUTP dUTP
a

Silica extraction method.

b

GuSCN, guanidine thiocyanate lysis and isopropanol precipitation.

c

MagnaPure (Roche Diagnostics).

d

QIAamp DNA mini kit (Qiagen).

e

Amplicor respiratory specimen preparation kit.

f

Equivalent (Eq.) sample used for PCR (in microliters), calculated as the starting volume used for concentration and extraction × fraction of extracted volume added to the amplification mixture.

g

?, participant did not answer.

h

ptxA Pr, pertussis toxin promoter.

i

Taqman double dye probe.

j

Addition of dUTP and uracil glycosylase.